Seven Brand-Drug Execs Agree To Testify At Finance Hearing

By John Wilkerson
February 6, 2019 at 6:59 PM
Updated Story: Since this story was first posted, all companies agreed to testify. Executives from the seven companies invited to testify about drug prices before the Senate Finance Committee have agreed to show up: AbbVie, Bristol-Meyers Squibb, Sanofi, Merck & Co, Pfizer, Johnson & Johnson’s Janssen, and AstraZeneca. After having a difficult time getting drug company executives to testify at a Jan. 29 hearing, Finance Chair Chuck Grassley (R-IA) and ranking committee Democrat Ron Wyden (OR) are...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.